Carolina Contreras Cuevas/LinkedIn
Oct 24, 2025, 10:03
Debunking Myths with Carolina Contreras Cuevas: The AQUARIUS Trial That Had to Be Stopped
Carolina Contreras Cuevas, Hematologist, Medical Center and Interconsultant Physician at RedSalud CCHC, shared a post on LinkedIn:
“Debunking Myths.
The AQUARIUS study on the use of ASA + anticoagulant (VKA or DOAC) in patients with chronic coronary syndrome, already with a stent implanted for >6 months, and on anticoagulation for another reason.
Spoiler: The study had to be stopped early at 2.2 years.”
Read full paper here.
Stay informed with Hemostasis Today.
-
Sep 30, 2026, 22:28Recent Mechanical Risk Factors and Young-Onset Cryptogenic Ischemic Stroke – American Heart Association International
-
Sep 30, 2026, 22:22Expert Consensus on Inferior Vena Cava Thrombosis – Thrombosis and Haemostasis Journal
-
Sep 30, 2026, 22:21Markus Abeln: How Platelets, Coagulation, Glycosylation, and Complement Regulate Placental Blood Flow
-
Sep 30, 2026, 22:19Fatma Al Arbawi: Studying Blood Clot Mechanics to Understand Aspirin Resistance and Thrombosis
-
Sep 30, 2026, 22:17Sudhir Kumar: Stroke is a Medical Emergency – and Every Minute Matters
-
Sep 30, 2026, 22:15Luisa Medeiros Visentini: Our Research on Cognitive Impairment After CVT Cited in the International Journal of Stroke
-
Sep 30, 2026, 21:50Jagat Narula: Connecting Cardiovascular Health and Sickle Cell Disease on World Heart Day 2026
-
Sep 30, 2026, 21:38John Kastelein: Exploring the Biology of Cardiovascular Disease at BioCentury Grand Rounds Europe
-
Sep 30, 2026, 21:36Mark Murphy: Irish Heart Foundation Meets With Senator Teresa Costello on World Heart Day